Linacip E 5/10 Tablet 10 is prescribed as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It falls under a class of medications known as a sodium-glucose cotransporter 2 (SGLT2) inhibitor and dipeptidyl peptidase-4 (DPP-4) inhibitor.
This tablet is also used in reducing the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. This combination is considered when treatment with both empagliflozin and linagliptin is appropriate.
This medicine is not recommended for patients with type 1 diabetes or diabetic ketoacidosis. It has also not been studied in patients with a history of pancreatitis. Before starting treatment, consult your doctor about your complete health profile and any medicines you are currently taking.